Richard Barry, Director at Sarepta Therapeutics, Inc. (SRPT), sold 75,000 shares at $130.34 ($9.8M) on 2018-06-27, disclosed to the SEC on 2018-06-29.
Open-market sale of $9.8M SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SAVA | BUY | 2025-11-24 | $828K | — | Filing → |
| SAVA | BUY | 2025-11-20 | $404K | — | Filing → |
| SAVA | BUY | 2025-09-23 | $16K | — | Filing → |